Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

481 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Skin IL-17A and IFN-γ Production Correlate with Disease Severity in Patients with Psoriasis and Streptococcal Infection.
Della Bella C, Corrà A, Mantengoli E, Galano A, Benagiano M, Bonciani D, Mariotti EB, Pratesi S, Quintarelli L, Aimo C, Grassi A, D'Elios S, Volpi W, Verdelli A, Bartoloni A, Rossolini GM, D'Elios MM, Caproni M. Della Bella C, et al. Among authors: bartoloni a. J Invest Dermatol. 2023 Jun;143(6):925-932. doi: 10.1016/j.jid.2022.10.025. Epub 2023 Jan 13. J Invest Dermatol. 2023. PMID: 36642401
Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19.
Graziani L, Gori L, Manciulli T, Basile G, Campolmi I, Borchi B, di Dio M, Mattei M, Ciurleo G, Ciliberti M, Malentacchi F, Coppi M, Morettini A, Parronchi P, Rossolini GM, Bartoloni A, Tomassetti S, Spinicci M. Graziani L, et al. Among authors: bartoloni a. J Antimicrob Chemother. 2023 Feb 1;78(2):555-558. doi: 10.1093/jac/dkac433. J Antimicrob Chemother. 2023. PMID: 36544352 Free PMC article. No abstract available.
Combination regimen of nirmatrelvir/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: A case report and a scoping review of the literature.
Marangoni D, Antonello RM, Coppi M, Palazzo M, Nassi L, Streva N, Povolo L, Malentacchi F, Zammarchi L, Rossolini GM, Vannucchi AM, Bartoloni A, Spinicci M. Marangoni D, et al. Among authors: bartoloni a. Int J Infect Dis. 2023 Aug;133:53-56. doi: 10.1016/j.ijid.2023.04.412. Epub 2023 May 5. Int J Infect Dis. 2023. PMID: 37150351 Free PMC article. Review.
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience.
Piccica M, Spinicci M, Botta A, Bianco V, Lagi F, Graziani L, Faragona A, Parrella R, Giani T, Bartolini A, Morroni G, Bernardo M, Rossolini GM, Tavio M, Giacometti A, Bartoloni A. Piccica M, et al. Among authors: bartoloni a. J Antimicrob Chemother. 2023 Nov 6;78(11):2752-2761. doi: 10.1093/jac/dkad298. J Antimicrob Chemother. 2023. PMID: 37807834 Free PMC article.
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients.
Nannini G, Di Gloria L, Russo E, Sterrantino G, Kiros ST, Coppi M, Niccolai E, Baldi S, Ramazzotti M, Di Pilato V, Lagi F, Bartolucci G, Rossolini GM, Bartoloni A, Amedei A. Nannini G, et al. Among authors: bartoloni a. Microbes Infect. 2024 Apr 16:105339. doi: 10.1016/j.micinf.2024.105339. Online ahead of print. Microbes Infect. 2024. PMID: 38636822 Free article.
Utility of bronchoalveolar lavage for COVID-19: a perspective from the Dragon consortium.
Tomassetti S, Ciani L, Luzzi V, Gori L, Trigiani M, Giuntoli L, Lavorini F, Poletti V, Ravaglia C, Torrego A, Maldonado F, Lentz R, Annunziato F, Maggi L, Rossolini GM, Pollini S, Para O, Ciurleo G, Casini A, Rasero L, Bartoloni A, Spinicci M, Munavvar M, Gasparini S, Comin C, Cerinic MM, Peired A, Henket M, Ernst B, Louis R, Corhay JL, Nardi C, Guiot J. Tomassetti S, et al. Among authors: bartoloni a. Front Med (Lausanne). 2024 Feb 2;11:1259570. doi: 10.3389/fmed.2024.1259570. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38371516 Free PMC article. Review.
Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA).
Paniagua-García M, Bravo-Ferrer JM, Pérez-Galera S, Kostyanev T, de Kraker MEA, Feifel J, Palacios-Baena ZR, Schotsman J, Cantón R, Daikos GL, Carevic B, Dragovac G, Tan LK, Raka L, Hristea A, Viale P, Akova M, Cano Á, Reguera JM, Bartoloni A, Florescu SA, Benea S, Bukarica L, Asensio Á, Korten V, Grundmann H, Goossens H, Bonten MJ, Gutiérrez-Gutiérrez B, Rodríguez-Baño J; COMBACTE-CARE-EURECA team. Paniagua-García M, et al. Among authors: bartoloni a. Clin Microbiol Infect. 2024 Feb;30(2):223-230. doi: 10.1016/j.cmi.2023.11.008. Clin Microbiol Infect. 2024. PMID: 38267096 Free article.
Identification of asymptomatic Leishmania infection in patients undergoing kidney transplant using multiple tests.
Deni A, De Pascali AM, Ortalli M, Balducelli E, Provenzano M, Ferrara F, Busutti M, La Manna G, Zammarchi L, Bartoloni A, Caroti L, Ibarra-Meneses AV, Carrillo E, Comai G, Varani S. Deni A, et al. Among authors: bartoloni a. Int J Infect Dis. 2024 Jan;138:81-83. doi: 10.1016/j.ijid.2023.11.012. Epub 2023 Nov 22. Int J Infect Dis. 2024. PMID: 37995832 Free article.
481 results